"Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.
Descriptor ID |
D014612
|
MeSH Number(s) |
D20.215.894
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Vaccines".
This graph shows the total number of publications written about "Vaccines" by people in this website by year, and whether "Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 3 | 3 |
1996 | 1 | 0 | 1 |
1997 | 2 | 0 | 2 |
1998 | 1 | 2 | 3 |
1999 | 2 | 1 | 3 |
2000 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2002 | 3 | 0 | 3 |
2003 | 1 | 3 | 4 |
2004 | 1 | 0 | 1 |
2005 | 5 | 7 | 12 |
2006 | 5 | 1 | 6 |
2007 | 1 | 1 | 2 |
2008 | 6 | 2 | 8 |
2009 | 1 | 2 | 3 |
2010 | 8 | 0 | 8 |
2011 | 9 | 1 | 10 |
2012 | 4 | 1 | 5 |
2013 | 13 | 3 | 16 |
2014 | 14 | 4 | 18 |
2015 | 9 | 1 | 10 |
2016 | 14 | 1 | 15 |
2017 | 10 | 4 | 14 |
2018 | 6 | 3 | 9 |
2019 | 14 | 6 | 20 |
2020 | 14 | 4 | 18 |
2021 | 15 | 1 | 16 |
2022 | 22 | 1 | 23 |
2023 | 18 | 1 | 19 |
2024 | 7 | 0 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccines" by people in Profiles.
-
Frequency of vaccine hesitancy among patients with advanced cancer. Palliat Support Care. 2024 Apr; 22(2):289-295.
-
Low antibody levels associated with significantly increased rate of SARS-CoV-2 infection in a highly vaccinated population from the US National Basketball Association. J Med Virol. 2024 Mar; 96(3):e29505.
-
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021 Emerg Infect Dis. 2024 02; 30(2):245-254.
-
Interferon response and profiling of interferon response genes in peripheral blood of vaccine-naive COVID-19 patients. Front Immunol. 2023; 14:1315602.
-
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial. Nat Med. 2024 Feb; 30(2):531-542.
-
Immuno-Oncology: New Insights into Targets and Therapies. Surg Oncol Clin N Am. 2024 Apr; 33(2):265-278.
-
Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):174-185.
-
Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact. Viruses. 2023 Dec 28; 16(1).
-
SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months-4 Years - New Vaccine Surveillance Network, United States, July 2022-September 2023. MMWR Morb Mortal Wkly Rep. 2023 Dec 01; 72(48):1300-1306.
-
The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection. PLoS Negl Trop Dis. 2023 Nov; 17(11):e0011519.